Hinge Health Inc. Class A Common Stock vs NextEra Energy, Inc. — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.96 (market cap $8.48B), while NextEra Energy, Inc. trades at $79.29 (market cap $163.17B). The key difference: NextEra Energy, Inc. is far larger — about 19.2× Hinge Health Inc. Class A Common Stock's market cap, and NextEra Energy, Inc. pays a 3.19% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and NextEra Energy, Inc. for 83 Days on average.
| HNGE | NEE | |
|---|---|---|
Market Cap | $8.48B | $163.17B |
Volume | 879,799 | 9,492,162 |
Sector | Health | Utilities |
52-Week High | $105.14 | $97.88 |
52-Week Low | $31.17 | $75.49 |
Typical Hold Time | 0 Days | 83 Days |
Enterprise Value | $8.10B | $270.50B |
Dividend Yield | — | 3.19% |
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
NextEra Energy (NEE) trades at $78.22, down 0.37% on the day, with a bullish technical signal despite mixed indicators. The stock shows strong fundamentals with a P/E of 17.58, net income margin of 32.4%, and recent earnings beats in Q1 and Q2 2026. Recent news highlights growth initiatives, including a $22.3 billion energy infrastructure project in Texas, positioning the company for expansion amid a 66.66% analyst buy rating.
Outlook remains positive with a consensus price target of $95.60, offering ~22% upside. Key risks include rising debt-to-asset ratios (47.6% in 2025) and interest rate sensitivity. Investors should weigh strong profitability against capital expenditure demands and macroeconomic pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →